DENTSPLY SIRONA Inc. $XRAY Shares Sold by Cetera Investment Advisers

Cetera Investment Advisers lowered its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 29.3% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 21,225 shares of the medical instruments supplier’s stock after selling 8,801 shares during the period. Cetera Investment Advisers’ holdings in DENTSPLY SIRONA were worth $317,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also made changes to their positions in XRAY. Barclays PLC increased its holdings in shares of DENTSPLY SIRONA by 13.8% during the 4th quarter. Barclays PLC now owns 349,112 shares of the medical instruments supplier’s stock worth $6,625,000 after buying an additional 42,303 shares during the last quarter. CANADA LIFE ASSURANCE Co increased its holdings in DENTSPLY SIRONA by 14.7% in the 4th quarter. CANADA LIFE ASSURANCE Co now owns 212,681 shares of the medical instruments supplier’s stock valued at $4,034,000 after purchasing an additional 27,246 shares during the last quarter. First Trust Advisors LP increased its holdings in DENTSPLY SIRONA by 4.2% in the 4th quarter. First Trust Advisors LP now owns 270,363 shares of the medical instruments supplier’s stock valued at $5,131,000 after purchasing an additional 10,980 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in DENTSPLY SIRONA by 21.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 6,851,869 shares of the medical instruments supplier’s stock valued at $130,045,000 after purchasing an additional 1,230,944 shares during the last quarter. Finally, MetLife Investment Management LLC increased its holdings in DENTSPLY SIRONA by 7.0% in the 4th quarter. MetLife Investment Management LLC now owns 112,113 shares of the medical instruments supplier’s stock valued at $2,128,000 after purchasing an additional 7,351 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

DENTSPLY SIRONA stock opened at $14.03 on Wednesday. The stock has a market cap of $2.80 billion, a P/E ratio of -2.96, a price-to-earnings-growth ratio of 0.86 and a beta of 0.94. The company has a fifty day simple moving average of $15.37 and a 200-day simple moving average of $15.60. DENTSPLY SIRONA Inc. has a 12-month low of $12.16 and a 12-month high of $27.48. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.02. The business had revenue of $936.00 million during the quarter, compared to analysts’ expectations of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The company’s revenue for the quarter was down 4.9% on a year-over-year basis. During the same period in the previous year, the company earned $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Equities analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Investors of record on Friday, September 26th will be paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 4.6%. The ex-dividend date is Friday, September 26th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -13.50%.

Analyst Upgrades and Downgrades

XRAY has been the subject of several research reports. Stifel Nicolaus dropped their target price on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a report on Friday, August 8th. Wells Fargo & Company dropped their target price on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating for the company in a report on Friday, August 8th. UBS Group dropped their target price on shares of DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating for the company in a report on Friday, August 8th. Barrington Research dropped their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating for the company in a report on Friday, August 8th. Finally, Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a research report on Monday, July 21st. Two equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $18.64.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.